SAGE - セ―ジ・セラピュ―ティクス （Sage Therapeutics Inc.） セ―ジ・セラピュ―ティクス

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will present at the Piper Sandler 34th Annual Healthcare Conference on Thursday, December 1, 2022, at 8:00 a.m. ET in New York, NY. A live webcast of the presentation can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the c

The share price of Sage Therapeutics Inc. (NASDAQ:SAGE) fell to $35.04 per share on Thursday from $35.12. While Sage Therapeutics Inc. has underperformed by -0.23%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, SAGE fell by -15.05%, with highs and lows ranging from $45.74 to $27.36, […]

While the markets are digesting the active growth of retail sales in the United States in October of this year, which is likely to spur inflation by the end of the year and create several problems for the Federal Reserve System, Twitter CEO Elon Musk sent an email throughout the company to the remaining employees. He demands that they commit to working longer than usual and with high intensity, or they can receive severance pay for three months and leave the company - if they do not agree with these conditions. The ultimatum of the entire company followed the dismissal of key Twitter executives, half of Twitter''s full-time employees, and the reduction of a number of contractors without prior notice. This week, he also fired veteran Twitter engineers who criticized him publicly. Remember that after Musk took office on October 28, he announced large-scale changes planned for Twitter 2.0. However, his first proposal to introduce a Twitter Blue subscription had to be canceled. The $7.99-per-month Blue subscription service provided users with a blue checkmark that resembled an earlier mark, indicating that the account had been verified and was official.

Barry E Greene , President and CEO at Sage Therapeutics (NASDAQ: SAGE ), reported a large insider buy on November 15, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Greene purchased 14,500 shares of Sage Therapeutics. The total transaction amounted to $500,022. Sage Therapeutics shares are trading up 2.99% at $36.3 at the time of this writing on Wednesday morning. Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm. Why Insider Transactions Are Important Insider transactions shouldn''t be used primarily … Full story available on Benzinga.com

Sage Therapeutics (SAGE) on Tuesday has appointed Laura Gault, MD, Ph.D. as Chief Medical Officer. In her new role, Dr

https://www.investing.com/news/pro/update-loop-capital-starts-sage-therapeutics-at-hold-432SI-2927731

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that i

Sage Therapeutics Inc (NASDAQ: SAGE ) and Biogen Inc (NASDAQ: BIIB ) presented additional data from the Phase 3 SKYLARK Study of zuranolone in adult women with postpartum depression (PPD). The SKYLARK Study, as previously reported, achieved the primary and all key secondary endpoints. Zuranolone 50 mg showed a statistically significant and clinically meaningful improvement in depressive symptoms at … Full story available on Benzinga.com

WESTON (dpa-AFX) - Sage Therapeutics, Inc. (SAGE) and Biogen Inc. (BIIB) announced Monday additional data from the Phase 3 SKYLARK Study of zuranolone in adult women with postpartum depression or …

Sage Therapeutics shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will present at the Morgan Stanley 20th Annual Global Healthcare Conference on Monday, September 12, 2022, at 3:40 p.m. ET in New York, NY. A live webcast of the presentation can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available approxi

The "brain health pandemic" since Covid struck exposed a glaring void: Current depression treatments don''t fit many patients'' needs. A group of biotech stocks hope to change that.

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Micron Technology Inc. (Symbol: MU), where a total volume of 89,906 contracts has been traded thus far today, a contract volume which is representative of appro